Reference
1. Ballerie A, Alix L, Bajeux E, Jégo P, Lescoat A, Hue B. The
collaboration of clinical pharmacists and physicians for medication
safety. Lancet, 2020; 394(10216):2240.
2. Hall W. ACP Journal Club. Review: pharmacist care improves
therapeutic and safety outcomes in older adults. Ann. Intern. Med. 2013;
159(10):JC6.
3. Lundberg G. The clinical pharmacist. JAMA. 1983; 249(9):1193.
4. Fuster V. No Such Thing as Ideal Blood Pressure: A Case for
Personalized Medicine. J. Am. Coll. Cardiol. 2016; 67(25):3014-15.
5. Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R,
et al. Randomized Trial of the Effect of Pharmacist Prescribing on
Improving Blood Pressure in the Community: The Alberta Clinical Trial in
Optimizing Hypertension (RxACTION). Circulation. 2015; 132(2):93-100.
6. Gomez A. Availability of Pharmacist-Prescribed Contraception in
California, 2017. JAMA. 2017; 318(22):2253-4.
7. Avery A, Pringle M. Extended prescribing by UK nurses and
pharmacists. BMJ. 2005; 331(7526):1154-5.
8. Kouladjian O’Donnell L, Sawan M. Deprescribing needs to be considered
in the pharmacists’ prescribing role. Med. J. Aust. 2020;
212(3):141-e141.
9. Abouk R, Pacula R, Powell D. Association Between State Laws
Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal
Overdose. JAMA Intern Med. 2019; 179(6):805-11.
10. Hill L, Reveles K, Evoy K. State-Level Approaches to Expanding
Pharmacists’ Authority to Dispense Naloxone May Affect Accessibility.
JAMA Intern Med. 2019; 179(10):1442-3.
11. Pearson G. Evolution in the practice of pharmacy–not a
revolution! CMAJ. 2007; 176(9):1295-6.
12. Sayburn A. Pharmacists could work in GP premises under proposed new
model of care. BMJ. 2015; 351:h4427.
13. Torjesen I. More than 400 pharmacists will be recruited to GP
surgeries by next year. BMJ. 2015; 351:h6167.
14. Friend S. Delegation of flu jabs: pharmacists are trained and
vigilant. BMJ. 2019; 367:l6884.
15. Tribble A, Lee B, Flett K, Handy L, Gerber J, Hersh A, et al.
Appropriateness of Antibiotic Prescribing in U.S. Children’s Hospitals:
A National Point Prevalence Survey. Clinical infectious diseases : an
official publication of the Infectious Diseases Society of America 2020.
https://doi.org/10.1093/cid/ciaa036
16. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing
errors in hospital inpatients: a prospective study. Lancet. 2002;
359(9315):1373-8.
17. Classen D, Pestotnik S, Evans R, Burke J. Computerized surveillance
of adverse drug events in hospital patients. JAMA. 1991;
266(20):2847-51.
18. Hawkey C, Hodgson S, Norman A, Daneshmend T, Garner S. Effect of
reactive pharmacy intervention on quality of hospital prescribing. BMJ.
1990; 300(6730):986-990.
19. Steinman M, Landefeld C. Overcoming Inertia to Improve Medication
Use and Deprescribing. JAMA. 2018; 320(18):1867-9.
20. Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A.
Evaluation of a pharmacist-led medication assessment used to identify
prevalence of and associations with polypharmacy and potentially
inappropriate medication use among ambulatory senior adults with cancer.
J. Clin. Oncol. 2015; 33(13):1453-9.
21. Zermansky A, Petty D, Raynor D, Freemantle N, Vail A, Lowe C.
Randomised controlled trial of clinical medication review by a
pharmacist of elderly patients receiving repeat prescriptions in general
practice. BMJ. 2001; 323(7325):1340-3.
22. Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a
Pharmacist-Led Educational Intervention on Inappropriate Medication
Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical
Trial. JAMA. 2018; 320(18):1889-98.
23. Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S, et
al. Effect of a pharmacist intervention on clinically important
medication errors after hospital discharge: a randomized trial. Ann.
Intern. Med. 2012; 157(1):1-10.
24. Tsuyuki R, Al Hamarneh Y, Jones C, Hemmelgarn B. The Effectiveness
of Pharmacist Interventions on Cardiovascular Risk: The Multicenter
Randomized Controlled RxEACH Trial. J. Am. Coll. Cardiol. 2016;
67(24):2846-2854.
25. Bland C, Jones B. Pharmacists Filling the Gap Within Penicillin
Allergy Assessment and Skin Testing. Clin. Infect. Dis. 2020.
https://doi.org/10.1093/cid/ciaa978
26. Leape L, Cullen D, Clapp M, Burdick E, Demonaco H, Erickson J, et
al. Pharmacist participation on physician rounds and adverse drug events
in the intensive care unit. JAMA. 1999; 282(3):267-270.
27. Green B, Cook A, Ralston J, Fishman P, Catz S, Carlson J, et al.
Effectiveness of home blood pressure monitoring, Web communication, and
pharmacist care on hypertension control: a randomized controlled trial.
JAMA. 2008; 299(24):2857-67.
28. Siegel D. ACP Journal Club: in uncontrolled hypertension, a
pharmacist-prescribing intervention reduced blood pressure at 6 months.
Ann. Intern. Med. 2015; 163(10):JC7.
29. Dunn S, Birtcher K, Beavers C, Baker W, Brouse S, Page R, et al. The
role of the clinical pharmacist in the care of patients with
cardiovascular disease. J. Am. Coll. Cardiol. 2015; 66(19):2129-2139.
30. Aluh D, Norberg M. Community pharmacists as a resource in
task-shifted interventions for depression. Lancet Psychiatry. 2020;
7(5):e24.
31. Radley A, de Bruin M, Inglis S, Donnan P, Hapca A, Barclay S, et al.
Clinical effectiveness of pharmacist-led versus conventionally delivered
antiviral treatment for hepatitis C virus in patients receiving opioid
substitution therapy: a pragmatic, cluster-randomised trial. The lancet
Gastroenterology & hepatology. 2020.
32. Franklin B, Abel G, Shojania K. Medication non-adherence: an
overlooked target for quality improvement interventions. BMJ Qual Saf.
2020; 29(4):271-3.
33. Mes M, Katzer C, Chan A, Wileman V, Taylor S, Horne R. Pharmacists
and medication adherence in asthma: a systematic review and
meta-analysis. Eur. Respir. J. 2018; 52(2): 1800485.
34. Sivaraman V, Wise K, Cotton W, Barbar-Smiley F, AlAhmed O, MacDonald
D, et al. Previsit Planning Improves Pneumococcal Vaccination Rates in
Childhood-Onset SLE. Pediatrics 2020; 145(1).
35. McKenney J, Slining J, Henderson H, Devins D, Barr M. The effect of
clinical pharmacy services on patients with essential hypertension.
Circulation. 1973; 48(5):1104-11.
36. Schulz M, Griese-Mammen N, Anker S, Koehler F, Ihle P, Ruckes C, et
al. Pharmacy-based interdisciplinary intervention for patients with
chronic heart failure: results of the PHARM-CHF randomized controlled
trial. Eur. J. Heart Fail. 2019; 21(8):1012-21.
37. Lowrie R, Mair F, Greenlaw N, Forsyth P, Jhund P, McConnachie A, et
al. Pharmacist intervention in primary care to improve outcomes in
patients with left ventricular systolic dysfunction. Eur. Heart J. 2012;
33(3):314-24.
38. Straus S, Dolovich L. In hospitalized adults with polypharmacy, a
multifaceted pharmacist intervention reduced readmissions at 180 days.
Ann. Intern. Med. 2018; 168(10):JC59.
39. Lapointe-Shaw L, Bell C, Austin P, Abrahamyan L, Ivers N, Li P, et
al. Community pharmacy medication review, death and re-admission after
hospital discharge: a propensity score-matched cohort study. BMJ Qual
Saf. 2020; 29(1):41-51.
40. Morgan S, Bathula H, Moon S. Pricing of pharmaceuticals is becoming
a major challenge for health systems. BMJ. 2020; 368:l4627.
41. Caplan A. Obtaining prescription drugs in America: it’s no bargain.
J. Clin. Invest. 2019; 129(11):4558-9.
42. Buckley M, Knutson K, Agarwal S, Lansburg J, Wicks L, Saggar R, et
al. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and
Costs in the Critically Ill. Ann Pharmacother. 2020; 54(2):105-112.
43. Muñoz-Pichuante D, Villa-Zapata L. Benefit of Incorporating Clinical
Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Journal of clinical pharmacy and therapeutics 2020.
https://doi.org/10.1111/jcpt.13195
44. Hyland S, Kramer B, Fada R, Lucki M. Clinical Pharmacist Service
Associated With Improved Outcomes and Cost Savings in Total Joint
Arthroplasty. The Journal of arthroplasty 2020.
https://doi.org/10.1016/j.arth.2020.04.022
45. Abdulrhim S, Sankaralingam S, Ibrahim M, Awaisu A. The impact of
pharmacist care on diabetes outcomes in primary care settings: An
umbrella review of published systematic reviews. Primary care diabetes
2020. https://doi.org/10.1016/j.pcd.2019.12.007
46. Rimmer A. Shortened medical training for physiotherapists and
pharmacists must not reduce standards, doctors warn. BMJ. 2020;
368:m551.
47. Boulanger Renaud F.(2011). Transforming health professionals’
education. Lancet, 377(9773), 1237; author reply 1238-9.
doi:10.1016/S0140-6736(11)60497-2.
48. McCrary M, Goldstein J. Pharmacist-Led Education to Discontinue
Inappropriate Prescribing. JAMA. 2019; 321(13):1313-4.
49. Johnson K, Khakban A, Bryan S, Sin D, Sadatsafavi M. Healthcare
system encounters before COPD diagnosis: a registry-based longitudinal
cohort study. Thorax. 2020; 75(2):108-15.